|
Drug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases |
|
|
1 | (5) |
|
Nursing Process and Client Teaching |
|
|
6 | (2) |
|
Principles of Drug Administration |
|
|
8 | (4) |
|
Medication and Calculations |
|
|
12 | (38) |
|
The Drug Approval Process, Resources, and Ethical Considerations |
|
|
50 | (3) |
|
Transcultural Considerations |
|
|
53 | (4) |
|
Drug Interactions, Over-the-Counter Drugs, and Drug Abuse |
|
|
57 | (3) |
|
Herbal Therapy with Nursing Implications |
|
|
60 | (3) |
|
Drug Therapy Considerations Throughout the Life Span |
|
|
63 | (4) |
|
Medication Administration in Community Settings |
|
|
67 | (2) |
|
The Role of the Nurse in Drug Research |
|
|
69 | (2) |
|
Vitamin and Mineral Replacement |
|
|
71 | (3) |
|
Fluid and Electrolyte Replacement |
|
|
74 | (6) |
|
|
|
80 | (4) |
|
Central Nervous System Stimulants |
|
|
84 | (3) |
|
Central Nervous System Depressants: Sedative-Hyponotics and Anesthetics |
|
|
87 | (3) |
|
Nonnarcotic and Narcotic Analgesics |
|
|
90 | (5) |
|
|
|
95 | (5) |
|
Antipsychotics, Anxiolytics, and Antidepressants |
|
|
100 | (7) |
|
Autonomic Nervous System Agents |
|
|
107 | (2) |
|
Adrenergics and Adrenergic Blockers |
|
|
109 | (4) |
|
Cholinergics and Anticholinergics |
|
|
113 | (4) |
|
Drugs for Neuromuscular Disorders: Parkinsonism, Myasthenia Gravis, Multiple Sclerosis, Alzheimer's Disease, and Muscle Spasms |
|
|
117 | (5) |
|
|
|
122 | (5) |
|
Antibacterials: Penicillins and Cephalosporins |
|
|
127 | (4) |
|
Antibacterials: Macrolides, Tetracyclines, Aminoglycosides, and Fluoroquinolones |
|
|
131 | (4) |
|
Antibacterial: Sulfonamides |
|
|
135 | (3) |
|
Antitubercular Drugs, Antifungal Drugs, Peptides, and Metronidazole |
|
|
138 | (4) |
|
Antiviral, Antimalarial, and Anthelmintic Drugs |
|
|
142 | (3) |
|
Drugs for Urinary Tract Disorders |
|
|
145 | (3) |
|
Human Immunodeficiency Virus-Related Agents |
|
|
148 | (4) |
|
|
|
152 | (3) |
|
|
|
155 | (5) |
|
Biologic Response Modifiers |
|
|
160 | (4) |
|
Drugs for Common Upper Respiratory Infections |
|
|
164 | (3) |
|
Drugs for Acute and Chronic Lower Respiratory Disorders |
|
|
167 | (4) |
|
Drugs for Cardiac Disorders |
|
|
171 | (7) |
|
|
|
178 | (5) |
|
|
|
183 | (5) |
|
Drugs for Circulatory Disorders |
|
|
188 | (6) |
|
Drugs for Gastrointestinal Tract Disorders |
|
|
194 | (5) |
|
|
|
199 | (6) |
|
Drugs for Disorders of the Eye and Ear |
|
|
205 | (4) |
|
Drugs for Dermatologic Disorders |
|
|
209 | (3) |
|
Endocrine Pharmacology: Pituitary, Thyroid, Parathyroids, and Adrenals |
|
|
212 | (5) |
|
|
|
217 | (7) |
|
Drugs Associated with the Female Reproductive Cycle: Pregnancy, Preterm Neonate, Labor, and Delivery |
|
|
224 | (8) |
|
Drugs Associated with the Postpartum and the Newborn |
|
|
232 | (6) |
|
Drugs Related to Women's Health and Disorders |
|
|
238 | (7) |
|
Drugs Related to Reproductive Health: Male Reproductive Disorders |
|
|
245 | (3) |
|
Drugs Related to Reproductive Health: Infertility and Sexually Transmitted Diseases |
|
|
248 | (4) |
|
Adult and Pediatric Emergency Drugs |
|
|
252 | (65) |
|
|
|
258 | (59) |
| Appendix A Basic Math Review |
|
317 | (9) |
| Appendix B Therapeutic Drug Monitoring |
|
326 | (5) |
| Appendix C Prototype Drug Chart |
|
331 | |
Other versions by this Author
